CLINICAL_TRIALS
trial_result
· 2017-08-18
Clinical Trial Update: Domperidone in Refractory Gastroparesis [Phase 2]
Summary
Phase 2 trial of domperidone in refractory gastroparesis was terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Gastroparesis | Phase 2 | Status: TERMINATED | Results posted: 2017-08-18